<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39373590</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2146-3077</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>Turkiye parazitolojii dergisi</Title><ISOAbbreviation>Turkiye Parazitol Derg</ISOAbbreviation></Journal><ArticleTitle>Cutaneous Leishmaniasis in Dr. Ersin Arslan Training and Research Hospital After Migration and During the Pandemic (2019-2022).</ArticleTitle><Pagination><StartPage>160</StartPage><EndPage>163</EndPage><MedlinePgn>160-163</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4274/tpd.galenos.2024.36349</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Cutaneous leishmaniasis is a parasitic skin disease transmitted by the bite of sandflies. In our region, which is endemic for this disease, there has been a great migration from a much more endemic region and population movements from our area to Türkiye and abroad. Afterward, a pandemic was experienced. Due to these two extraordinary events and the possible epidemic potential in our region, it is useful to follow-up on the disease. We aimed to contribute to the evaluation of the disease in these processes by analyzing the data of our laboratory in recent years.</AbstractText><AbstractText Label="METHODS">Between January 2019 and December 2022, samples from patients who came to our laboratory with suspected cutaneous leishmaniasis were taken, stained and examined under a microscope. Patients were evaluated in terms of age, gender, nationality, place of residence, lesion site and duration.</AbstractText><AbstractText Label="RESULTS">Out of the 144 examined cases, 64 (44.4%) were positive for cutaneous leishmaniasis. Among these positive cases, 40 (62.5%) were women, 24 (37.5%) were men, and 54 (84.3%) belonged to the 0-9 age group. Of those who tested positive, 54 (84.3%) were Turkish citizens and 23 (35.9%) were Syrian citizens. Fifty-four (84.3%) patients had only single lesion. While the number of applications and positivity rates remained within normal levels in 2019 and 2020, a significant decrease was observed in both from 2021 and 2022.</AbstractText><AbstractText Label="CONCLUSION">Cutaneous leishmaniasis is carried by migration, decreases in large-scale isolations such as pandemics, and its spread can be prevented with correct diagnosis and treatment. Although the number of patients may change over time and place, cutaneous leishmaniasis is a disease that threatens the health of societies and should always be monitored.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Özkeklikçi</LastName><ForeName>Ahmet</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1619-4156</Identifier><AffiliationInfo><Affiliation>Gaziantep City Hospital, Microbiology/Parasitology Laboratory, Gaziantep, Türkiye.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Dr. Ersin Arslan Eğitim ve Araştırma Hastanesi’nde Göç Sonrası ve Pandemi Sırasında Kutanöz Leishmaniasis (2019-2022).</VernacularTitle></Article><MedlineJournalInfo><Country>Turkey</Country><MedlineTA>Turkiye Parazitol Derg</MedlineTA><NlmUniqueID>9425544</NlmUniqueID><ISSNLinking>1300-6320</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016773" MajorTopicYN="Y">Leishmaniasis, Cutaneous</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014421" MajorTopicYN="N" Type="Geographic">Turkey</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013593" MajorTopicYN="N" Type="Geographic">Syria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004641" MajorTopicYN="N">Emigration and Immigration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="tur"><AbstractText Label="AMAÇ">Kutanöz leishmaniasis, kum sineklerinin ısırmasıyla bulaşan paraziter bir deri hastalığıdır. İzi bırakan deri lezyonlarına neden olur. Bu hastalık açısından endemik olan bölgemize çok daha endemik olan bir bölgeden büyük bir göç ve bölgemizden de yurt içine ve yurt dışına nüfus hareketleri olmuştur. Sonrasında bir pandemi yaşanmıştır. Bu iki olağanüstü olay ve bölgemizdeki olası epidemi potansiyeli nedeni ile hastalığın takibinde yarar vardır. Laboratuvarımızın son yıllardaki verilerini analiz ederek bu süreçlerde hastalığı değerlendirmesine katkı sağlamayı amaçladık.</AbstractText><AbstractText Label="YÖNTEMLER">Ocak 2019-Aralık 2022 tarihleri arasında laboratuvarımıza kutanöz leishmaniasis şüphesiyle gelen hastalardan örnekler alınmış, boyanmış ve mikroskop altında incelenmiştir. Hastalar yaş, cinsiyet, uyruk, ikamet yeri, lezyon bölgesi ve süresi açısından değerlendirilmiştir.</AbstractText><AbstractText Label="BULGULAR">İncelenen 144 olgunun 64’ünde (%44,4) kutanöz leishmaniasis pozitif bulunmuştur. Bu pozitif olguların 40’ı (%62,5) kadın, 24’ü (%37,5) erkek ve 54’ü (%84,3) 0-9 yaş grubuna aitti. Test sonucu pozitif çıkanların 54’ü (%84,3) Türk vatandaşı, 23’ü (%35,9) ise Suriye vatandaşıydı. Hastaların 54’ünde (%84,3) sadece tek lezyon vardı. Başvuru sayısı ve pozitiflik oranları 2019 ve 2020 yıllarında normal seviyelerde seyrederken, 2021 ve 2022 yıllarında her ikisinde de belirgin bir düşüş gözlenmiştir.</AbstractText><AbstractText Label="SONUÇ">Kutanöz leishmaniasis göçlerle taşınmakta, pandemi gibi büyük ölçekli izolasyonlarda azalmakta, doğru tanı ve tedavi ile yayılımı önlenebilmektedir. Hasta sayısı zaman ve mekana göre değişse de kutanöz leishmaniasis toplumların sağlığını tehdit eden ve her zaman takibi gereken bir hastalıktır.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cutaneous leishmaniasis</Keyword><Keyword MajorTopicYN="N">migration</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword><Keyword MajorTopicYN="N">Türkiye</Keyword><Keyword MajorTopicYN="N">Syria</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>9</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39373590</ArticleId><ArticleId IdType="doi">10.4274/tpd.galenos.2024.36349</ArticleId></ArticleIdList></PubmedData></PubmedArticle>